Scinopharm Taiwan, Ltd.(TW:1789)
NT$20.00-0.25 (-1.23%)
TW:1789
Scinopharm Taiwan, Ltd. financials statements
NT$20.00
At close:-0.25 (-1.23%)
Scinopharm Taiwan, Ltd. (1789) Income Statement
Scinopharm Taiwan, Ltd. Income Statement
Last quarter (Q2 2026), Scinopharm Taiwan, Ltd.'s total revenue was NT$678.50M, a decrease of 9.23% from the same quarter last year. In Q2, Scinopharm Taiwan, Ltd.'s net income was NT$-35.53M. See Scinopharm Taiwan, Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 3.16B | NT$ 3.41B | NT$ 3.19B | NT$ 3.26B | NT$ 2.76B | |
| NT$ 1.10B | NT$ 1.30B | NT$ 1.22B | NT$ 1.25B | NT$ 1.28B | |
| NT$ 987.53M | NT$ 977.50M | NT$ 901.50M | NT$ 845.27M | NT$ 991.87M | |
| Depreciation and Amortization | NT$ 516.73M | NT$ 488.28M | NT$ 461.17M | NT$ 439.46M | NT$ 381.53M |
| NT$ 673.97M | NT$ 909.38M | NT$ 819.15M | NT$ 885.34M | NT$ 690.37M | |
| NT$ 108.91M | NT$ 322.71M | NT$ 314.49M | NT$ 405.63M | NT$ 288.74M | |
| NT$ 38.47M | NT$ 91.98M | NT$ 34.35M | NT$ 32.33M | NT$ 13.54M | |
| NT$ 147.38M | NT$ 413.02M | NT$ 348.84M | NT$ 437.96M | NT$ 302.29M | |
| NT$ 136.95M | NT$ 339.35M | NT$ 287.06M | NT$ 353.22M | NT$ 243.47M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.17 | NT$ 0.43 | NT$ 0.36 | NT$ 0.45 | NT$ 0.31 |
| Diluted EPS | NT$ 0.17 | NT$ 0.43 | NT$ 0.36 | NT$ 0.45 | NT$ 0.31 |
| Weighted Average Shares Outstanding | 805.59M | 790.74M | 792.33M | 790.74M | 790.74M |
| Weighted Average Shares Outstanding (Diluted) | 805.59M | 792.87M | 792.33M | 792.68M | 792.28M |
Currency in TWD
